beta-D-Galp-(1->2)-[beta-D-Glcp-(1->4)]-beta-D-Galp

Term ID

CHEBI:146765

Synonyms

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5R,6R)-4,6-dihydroxy-2-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-galacto-hexopyranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->4)]-beta-D-galacto-hexopyranose
beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-beta-D-galactopyranose
Gal(b1-2)[Glc(b1-4)]b-Gal

Definition

A trisaccharide that is β-D-galactopyranose in which the hydroxy groups at positions 2 and 4 have been converted to the corresponding β-D-galactopyranoside and β-D-glucopyranoside, respectively.

References

glygen:G05057XI
glytoucan:G05057XI

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->2)-[beta-D-Glcp-(1->4)]-beta-D-Galp

Phenotype where environments contain beta-D-Galp-(1->2)-[beta-D-Glcp-(1->4)]-beta-D-Galp

Phenotype modified by environments containing beta-D-Galp-(1->2)-[beta-D-Glcp-(1->4)]-beta-D-Galp

Phenotype affecting beta-D-Galp-(1->2)-[beta-D-Glcp-(1->4)]-beta-D-Galp

Human Disease Model